AssetMark’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
AssetMark's FBT Position: Q3 2026 in Review
AssetMark reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 7.7% in Q3 2026, selling an estimated $487K and leaving 22,567 shares worth $6.14M. The position accounts for 0.01% of the portfolio, ranked #688.
AssetMark first reported a position in FBT in Q1 2019 and has held it in 21 quarters since. The position peaked at $11.1M in Q1 2026. 311 funds tracked by Wall St. Rank hold FBT as of Q3 2026.
- AssetMark held 22,567 shares of First Trust NYSE Arca Biotechnology Index Fund worth $6.14M as of Q3 2026.
- AssetMark sold 1,873 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $487K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of AssetMark's portfolio in Q3 2026, its #688 holding.
- AssetMark first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 21 quarters since.
- AssetMark's First Trust NYSE Arca Biotechnology Index Fund position peaked at $11.1M in Q1 2026.
- 311 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.